Editorial Comment on: Long-Term Survival after Gemcitabine and Cisplatin in Patients with Locally Advanced Transitional Cell Carcinoma of the Bladder: Focus on Supplementary Treatment Strategies

2007 ◽  
Vol 52 (2) ◽  
pp. 486-487
Author(s):  
Juergen E. Gschwend
Keyword(s):  
Editorial Comment ◽  
Transitional Cell Carcinoma ◽  
Locally Advanced ◽  
Transitional Cell ◽  
Treatment Strategies ◽  
Term Survival ◽  
Supplementary Treatment ◽  
Carcinoma Of The Bladder ◽  
Gemcitabine And Cisplatin

scholarly journals Recurrent dermatomyositis manifesting as a sign of recurrent transitional cell carcinoma of urinary bladder: Long-term survival

2014 ◽  
Vol 6 (3) ◽  
pp. 264 ◽  
Author(s):  
Ghulam Nabi ◽  
John Fitzpatrick ◽  
WilliamA. Wallace ◽  
Stephen Lang ◽  
OmarM. Aboumarzouk ◽  
...  
Keyword(s):  
Urinary Bladder ◽  
Transitional Cell Carcinoma ◽  
Cell Carcinoma ◽  
Transitional Cell ◽  
Term Survival ◽  
Long Term Survival

scholarly journals Current State of Vascular Resections in Pancreatic Cancer Surgery

2015 ◽  
Vol 2015 ◽  
pp. 1-7 ◽  
Author(s):  
Thilo Hackert ◽  
Lutz Schneider ◽  
Markus W. Büchler
Keyword(s):  
Pancreatic Cancer ◽  
Adjuvant Treatment ◽  
Locally Advanced ◽  
Neoadjuvant Treatment ◽  
Treatment Strategies ◽  
Western World ◽  
Term Survival ◽  
Long Term Survival ◽  
Current State

Pancreatic cancer (PDAC) is the fourth leading cause of cancer-related mortality in the Western world and, even in 2014, a therapeutic challenge. The only chance for long-term survival is radical surgical resection followed by adjuvant chemotherapy which can be performed in about 20% of all PDAC patients by the time of diagnosis. As pancreatic surgery has significantly changed during the past years, extended operations, including vascular resections, have become more frequently performed in specialized centres and the border of resectability has been pushed forward to achieve a potentially curative approach in the respective patients in combination with neoadjuvant and adjuvant treatment strategies. In contrast to adjuvant treatment which has to be regarded as a cornerstone to achieve long-term survival after resection, neoadjuvant treatment strategies for locally advanced findings are currently under debate. This overview summarizes the possibilities and evidence of vascular, namely, venous and arterial, resections in PDAC surgery.

LONG-TERM FOLLOWUP OF INITIAL Ta GRADE 1 TRANSITIONAL CELL CARCINOMA OF THE BLADDER

1999 ◽  
Vol 162 (6) ◽  
pp. 1946-1950 ◽  
Author(s):  
B. LEBLANC ◽  
A.J. DUCLOS ◽  
F. BÉNARD ◽  
J. CÔTÉ ◽  
L. VALIQUETTE ◽  
...  
Keyword(s):  
Transitional Cell Carcinoma ◽  
Cell Carcinoma ◽  
Transitional Cell ◽  
Carcinoma Of The Bladder

IMPACT OF DIAGNOSTIC URETEROSCOPY ON LONG-TERM SURVIVAL IN PATIENTS WITH UPPER TRACT TRANSITIONAL CELL CARCINOMA

1999 ◽  
pp. 783-785 ◽  
Author(s):  
BENJAMIN N. HENDIN ◽  
STEVAN B. STREEM ◽  
HOWARD S. LEVIN ◽  
ERIC A. KLEIN ◽  
ANDREW C. NOVICK
Keyword(s):  
Transitional Cell Carcinoma ◽  
Cell Carcinoma ◽  
Transitional Cell ◽  
Term Survival ◽  
Long Term Survival ◽  
Upper Tract
Sign in / Sign up

Export Citation Format

Share Document